STUDY DETAILS

Study Name:
RItuximab for lupus Nephritis with remission as a Goal, an investigator-initiated randomized international open multicentric study - RING

Phase:
Phase 4 Clinical trial

EudraCT number:
2012-000314-13

National Investigator Coordinator:
Professor Doutor Carlos Vasconcelos (Centro Hospitalar do Porto)

Sponsor:
Cliniques Universitaires Saint-Luc, UniversiteĢ Catholique de Louvain, Bruxelas

Participating Countries:
Argentina, Austria, Belgium, Brazil, Colombia, Spain, France, Greece, The Netherlands, Italy, Japan, Morocco, Norway, United Kingdom, Czech Republic, Romania, Russia, Sweden, Switzerland, Turkey

Sites in Portugal:
Centro Hospitalar do Porto
Centro Hospitalar Lisboa Central – Hospital Curry Cabral
Centro Hospitalar Universitário de Coimbra

Status:
Recruitment

Ā© 2017 NOVA CRU. Todos os direitos reservados. Designed by NOVA IMS.